Advertisement

Traitement des séminomes avancés

  • D. Pasquier
  • É. Lartigau
  • A. Caty
  • A. Villers
Chapter
  • 190 Downloads
Part of the Monographies en urologie book series (MONOGRAPHIES)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Bray F, Sankila R, Ferlay J (2002) Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38: 99–166PubMedCrossRefGoogle Scholar
  2. 2.
    Steele GS, Richie JP, Stewart AK et al. (1999) The national cancer data base report on patterns of care for testicular carcinoma, 1985–1996. Cancer 86: 2171–83PubMedCrossRefGoogle Scholar
  3. 3.
    TNM classification of malignant tumours, 6th Edition, March 2002Google Scholar
  4. 4.
    Gholam D, Fizazi K, Terrier-Lacombe MJ et al. (2003) Advanced seminoma — treatment results and pronostic factors for survival after first line, cisplatin based chemotherapy and for patients with recurrent disease. A single institution experience in 145 patients. Cancer 98: 745–52PubMedCrossRefGoogle Scholar
  5. 5.
    Thomas GM, Rider WD, Dembo AJ et al. (1982) Seminoma of the testis: results of treatment and patterns of failure after radiation therapy. Int J Radiat Oncol Biol Phys 8: 165–74PubMedGoogle Scholar
  6. 6.
    Bauman GS, Venkatesan VM, Ago T et al. (1998) Postoperative radiotherapy for stage I/II seminoma: results for 212 patients. Int J Radiat Oncol Biol Phys 42: 313–7PubMedCrossRefGoogle Scholar
  7. 7.
    Ellerbroek NA, Tran LM, Selch MT et al. (1988). Testicular seminoma. A study of 103 cases treated at UCLA. Am J Clin Oncol 11: 93–9PubMedGoogle Scholar
  8. 8.
    Zagars GK, Babaian RJ (1987) The role of radiation in stage II testicular seminoma. Int J Radiat Oncol Biol Phys 13: 163–70PubMedGoogle Scholar
  9. 9.
    Andrews CF, Micaily B, Brady LW (1987) Testicular seminoma. Results of a program of megavoltage irradiation. Am J Clin Oncol 10: 491–5PubMedGoogle Scholar
  10. 10.
    Ball D, Barrett A, Peckham MJ et al. (1982) The management of metastatic seminoma testis. Cancer 50: 2289–94PubMedGoogle Scholar
  11. 11.
    Hunter M, Peschel RE (1989) Testicular seminoma. Results of the Yale University Experience, 1964–1984. Cancer 64: 1608–11PubMedGoogle Scholar
  12. 12.
    Lai PP, Bernstein MJ, Kim H (1994) Radiation therapy for stage I and II A testicular seminoma. Int J Radiat Oncol Biol Phys 28: 373–9PubMedGoogle Scholar
  13. 13.
    Whipple GL, Sagerman RH, Van Rooy EM (1997) Long term evaluation of postorchiectomy radiotherapy for stage II seminoma. Am J Clin Oncol 20: 196–201PubMedCrossRefGoogle Scholar
  14. 14.
    Lederman GS, Herman TS, Jochelson M et al. (1989) Radiation therapy of seminoma: 17-year experience at the Joint Center for radiation therapy. Radiother Oncol 14: 203–8PubMedCrossRefGoogle Scholar
  15. 15.
    Evensen JF, Fossa SD, Kjellevold K et al. (1985) Testicular seminoma: analysis of treatment and failure for stage II disease. Radiother Oncol 4: 55–61PubMedGoogle Scholar
  16. 16.
    Bayens YC, Helle PA, Van Putten WLJ et al. (1992) Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: benefits of a 10-year followup study. Radiother Oncol 25: 97–102PubMedCrossRefGoogle Scholar
  17. 17.
    Classen J, Schmidberger H, Meisner C et al. (2003) Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol. 21: 1101–6PubMedCrossRefGoogle Scholar
  18. 18.
    Zagars GK, Pollack A (2001) Radiotherapy for stage II testicular seminoma. Int J Radiat Oncol Biol Phys 51: 643–9PubMedCrossRefGoogle Scholar
  19. 19.
    Laukkanen E, Olivotto I, Jackson S (1988) Management of seminoma with bulky abdominal disease. Int J Radiat Oncol Biol Phys 14: 227–33PubMedGoogle Scholar
  20. 20.
    Green N, Broth E, George FW et al. (1983). Radiation therapy in bulky seminoma. Urology 21: 467–9PubMedCrossRefGoogle Scholar
  21. 21.
    Schmidberger H, Bamberg M, Meisner C et al. (1997) Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study. Int J Radiat Oncol Biol Phys 39: 321–6PubMedCrossRefGoogle Scholar
  22. 22.
    Dosmann MA, Zagars GK (1993) Postorchiectomy radiotherapy for stages I and II testicular seminoma. Int J Radiat Oncol Biol Phys 26: 381–90PubMedGoogle Scholar
  23. 23.
    Lederman GS, Sheldon TA, Chaffey JT et al. (1987) Cardiac disease after mediastinal irradiation for seminoma. Cancer 60: 772–6PubMedGoogle Scholar
  24. 24.
    Hanks GE, Peters T, Owen J (1992) Seminoma of the testis: long term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys 24: 913–9PubMedGoogle Scholar
  25. 25.
    Mirimanoff RO, Sinzig M, Kruger M et al. (1993) Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapy. Int J Radiat Oncol Biol Phys 27: 17–23PubMedGoogle Scholar
  26. 26.
    Weissbach L, Bussar-Maatz R, Löhrs U et al. (1999). Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Eur Urol 36: 601–8PubMedCrossRefGoogle Scholar
  27. 27.
    Chao CKS, Lai PP, Michalski JM et al. (1995) Secondary malignancy among seminoma patients treated with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 33: 831–5PubMedCrossRefGoogle Scholar
  28. 28.
    Travis LB, Curtis RE, Storm H et al. (1997) Risk of second malignant neoplasms among long term survivors of testicular cancer. J Natl Cancer Inst 89: 1429–39PubMedCrossRefGoogle Scholar
  29. 29.
    Rüther U, Dieckmann KP, Bussar-Maatz R et al. (2000) Second malignancies following pure seminoma. Oncology 58: 75–82PubMedGoogle Scholar
  30. 30.
    Schmidberger H, Virsik-Koepp P, Rave Frank M. (2001) Reciprocal translocations in patients with testicular seminoma before and after radiotherapy. Int J Radiat Oncol Biol Phys 50: 857–64PubMedCrossRefGoogle Scholar
  31. 31.
    Golbey RB (1970) The place of chemotherapy in the treatment of testicular tumors. JAMA. 213: 101–3PubMedCrossRefGoogle Scholar
  32. 32.
    Einhorn LH, Williams SD (1980) Chemotherapy of disseminated seminoma. Cancer Clin Trials 3: 307–13PubMedGoogle Scholar
  33. 33.
    Samuels ML, Lanzotti VJ, Holoye PY et al. (1976) Combination chemotherapy in germinal cell tumors. Cancer Treat Rev 3: 185–204PubMedGoogle Scholar
  34. 34.
    Mendenhall WL, Williams SD, Einhorn LH et al. (1981) Disseminated seminoma: reevaluation of treatment protocols. J Urol 126: 493–6PubMedGoogle Scholar
  35. 35.
    Stanton GF, Bosl GJ, Whitmore WF Jr et al. (1985) VAB-6 as initial treatment of patients with advanced seminoma. J Clin Oncol 3(3): 336–9PubMedGoogle Scholar
  36. 36.
    Logothetis CJ, Samuels ML, Ogden SL et al. (1987). Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term follow-up in 52 patients. J Urol 138: 789–94PubMedGoogle Scholar
  37. 37.
    Amato RJ, Ellerhorst J, Banks M et al. (1995) Carboplatin and ifosfamide and selective consolidation in advanced seminoma. Eur J Cancer 31A: 2223–8PubMedGoogle Scholar
  38. 38.
    Peckham MJ, Horwich A, Hendry WF (1985) Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer 52: 7–13PubMedGoogle Scholar
  39. 39.
    Horwich A, Dearnaley DP, Duchesne GM (1989) Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol 7: 1150–6PubMedGoogle Scholar
  40. 40.
    Horwich A, Dearnaley DP, A’Hern R et al. (1992) The activity of single-agent carboplatin in advanced seminoma. Eur J Cancer 28A: 1307–10PubMedGoogle Scholar
  41. 41.
    Schmoll HJ, Harstrick A, Bokemeyer C et al. (1993) Single-agent carboplatinum for advanced seminoma. A phase II study. Cancer 72: 237–43PubMedGoogle Scholar
  42. 42.
    Oliver RT, Lore S, Ong J (1990) Alternatives to radiotherapy in the management of seminoma. Br J Urol 65: 61–7PubMedCrossRefGoogle Scholar
  43. 43.
    Bosl GJ, Motzer RJ (1997) Testicular germ-cell cancer. N Engl J Med 337: 242–53PubMedCrossRefGoogle Scholar
  44. 44.
    Mencel PJ, Motzer RJ, Mazumdar M et al. (1994) Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 12: 120–6PubMedGoogle Scholar
  45. 45.
    Clemm C, Hartenstein R, Willich N et al. (1986) Vinblastine-ifosfamide-cisplatin treatment of bulky seminoma. Cancer 58: 2203–7PubMedGoogle Scholar
  46. 46.
    Amato RJ, Millikan R, Daliani D et al. (2000) Cyclophosphamide and carboplatin and selective consolidation in advanced seminoma. Clin Cancer Res 6: 72–7PubMedGoogle Scholar
  47. 47.
    Miller KD, Loehrer PJ, Gonin R et al. (1997) Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J Clin Oncol 15: 1427–31PubMedGoogle Scholar
  48. 48.
    Vuky J, Tickoo SK, Sheinfeld J et al. (2002) Salvage chemotherapy for patients with advanced pure seminoma. J Clin Oncol 20: 297–301PubMedCrossRefGoogle Scholar
  49. 49.
    International Germ Cell Cancer Collaborative Group (1997) International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15: 594–603Google Scholar
  50. 50.
    Fossa SD, Oliver RT, Stenning SP et al. (1997) Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy. Eur J Cancer 33: 1380–7PubMedCrossRefGoogle Scholar
  51. 51.
    Fossa SD, Kullmann G, Lien HH et al. (1989) Chemotherapy of advanced seminoma: clinical significance of radiological findings before and after treatment. Br J Urol 64: 530–4PubMedGoogle Scholar
  52. 52.
    Motzer R, Bosl G, Heelan R et al. (1987) Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J Clin Oncol 5: 1064–70PubMedGoogle Scholar
  53. 53.
    Duchesne GM, Stenning SP, Aass N et al. (1997) Radiotherapy after chemotherapy for metastatic seminoma — a diminishing role. MRC Testicular Tumour Working Party. Eur J Cancer 33: 829–35PubMedCrossRefGoogle Scholar
  54. 54.
    Schultz SM, Einhorn LH, Conces DJ Jr et al. (1989) Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol 7: 1497–503PubMedGoogle Scholar
  55. 55.
    Flechon A, Bompas E, Biron P et al. (2002) Management of post-chemotherapy residual masses in advanced seminoma. J Urol 168: 1975–9PubMedGoogle Scholar
  56. 56.
    Ravi R, Ong J, Oliver RT et al. (1999) The management of residual masses after chemotherapy in metastatic seminoma. BJU Int 83(6): 649–53PubMedCrossRefGoogle Scholar
  57. 57.
    Puc HS, Heelan R, Mazumdar M et al. (1996) Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol 14: 454–60PubMedGoogle Scholar
  58. 58.
    Herr HW, Sheinfeld J, Puc HS et al. (1997) Surgery for a post-chemotherapy residual mass in seminoma. J Urol 157(3): 860–2PubMedGoogle Scholar
  59. 59.
    Ganjoo KN, Chan RJ, Sharma M et al. (1999) Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma. J Clin Oncol 17: 3457–60PubMedGoogle Scholar
  60. 60.
    De Santis M, Bokemeyer C, Becherer A et al. (2001) Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol 19: 3740–4PubMedGoogle Scholar

Copyright information

© Springer-Verlag France, Paris 2006

Authors and Affiliations

  • D. Pasquier
    • 1
  • É. Lartigau
    • 1
  • A. Caty
    • 2
  • A. Villers
    • 3
  1. 1.Service de radiothéapie du Pr LartigauCRLCC Oscar LambretLille Cedex
  2. 2.Service d’oncologie uro-digestive du Pr AdenisCRLCC Oscar LambretLille Cedex
  3. 3.Service d’urologie du Pr BiserteLille Cedex

Personalised recommendations